Cargando…

Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 is a diagnostic and prognostic biomarker for hepatocellular carcinoma

BACKGROUND: Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 (P-Rex1) was reported to be a risk factor in several cancers, including breast cancer, lung cancer, and melanoma, but its expression and role in hepatocellular carcinoma (HCC) have not yet been fully studied. AIM: T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Yi, Zheng, Qiao, Yao, De-Jiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479560/ https://www.ncbi.nlm.nih.gov/pubmed/32953853 http://dx.doi.org/10.12998/wjcc.v8.i17.3774

Ejemplares similares

Feedback regulation between phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 and transforming growth factor β1 and prognostic value in gastric cancer
por: Shao, Qi, et al.
Publicado: (2020)

Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 1 (PREX1) is a Novel Predictor of Prognosis for Breast Cancer Patients: A Retrospective Case Series
por: Zhong, Ying, et al.
Publicado: (2019)

Nuclear Phosphatidylinositol 3,4,5-Trisphosphate Interactome Uncovers an Enrichment in Nucleolar Proteins
por: Mazloumi Gavgani, Fatemeh, et al.
Publicado: (2021)

Gliotoxin Suppresses Macrophage Immune Function by Subverting Phosphatidylinositol 3,4,5-Trisphosphate Homeostasis
por: Schlam, Daniel, et al.
Publicado: (2016)

Phosphatidylinositol 3,4,5-trisphosphate Localization in Recycling Endosomes Is Necessary for AP-1B–dependent Sorting in Polarized Epithelial Cells
por: Fields, Ian C., et al.
Publicado: (2010)

Defining the Functional Domain of Programmed Cell Death 10 through Its Interactions with Phosphatidylinositol-3,4,5-Trisphosphate
por: Dibble, Christopher F., et al.
Publicado: (2010)

Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson’s disease-related fibril polymorphism
por: Choong, Chi-Jing, et al.
Publicado: (2023)

New drug-like small molecule antagonizes phosphatidylinositol (3,4,5)-trisphosphate (PIP3) in patients with conotruncal heart defects
por: Fayez, Alaaeldin G., et al.
Publicado: (2023)

The Phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P(3)) Binder Rasa3 Regulates Phosphoinositide 3-kinase (PI3K)-dependent Integrin α(IIb)β(3) Outside-in Signaling
por: Battram, Anthony M., et al.
Publicado: (2017)

Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors
por: Franck, Martin, et al.
Publicado: (2020)

Synthesis and Cellular Labeling of Multifunctional Phosphatidylinositol Bis‐ and Trisphosphate Derivatives
por: Müller, Rainer, et al.
Publicado: (2021)

Salivary Fusobacterium nucleatum serves as a potential diagnostic biomarker for gastric cancer
por: Chen, Wen-Dan, et al.
Publicado: (2022)

Prognostic model of hepatocellular carcinoma based on cancer grade
por: Zhang, Guo-Xin, et al.
Publicado: (2023)

Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis
por: Li, Shao-Hua, et al.
Publicado: (2017)

Development of a prognostic scoring system for resectable hepatocellular carcinoma
por: Sposito, Carlo, et al.
Publicado: (2016)

Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma
por: Che, Feng, et al.
Publicado: (2022)

Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection
por: Rungsakulkij, Narongsak, et al.
Publicado: (2018)

Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
por: Zhang, Tong, et al.
Publicado: (2019)

Image quality and diagnostic performance of free-breathing diffusion-weighted imaging for hepatocellular carcinoma
por: Takayama, Yukihisa, et al.
Publicado: (2017)

Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma
por: Lee, Han Ah, et al.
Publicado: (2021)

Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer
por: Xie, Yuan, et al.
Publicado: (2017)

Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma
por: Jiang, Tao, et al.
Publicado: (2021)

Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma
por: Elshaarawy, Omar, et al.
Publicado: (2019)

Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model
por: Luo, Pan-Quan, et al.
Publicado: (2022)

Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization
por: Abuodeh, Yazan, et al.
Publicado: (2016)

Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study
por: Zhang, Ge, et al.
Publicado: (2022)

Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer
por: Gao, Jian-Feng, et al.
Publicado: (2022)

Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma
por: Pan, Peng-Ji, et al.
Publicado: (2021)

Circulating miR-21-5p level has limited prognostic value in patients with hepatocellular carcinoma and is influenced by renal function
por: Franck, Martin, et al.
Publicado: (2020)

Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence
por: Zhang, Wei, et al.
Publicado: (2017)

Management of endoscopic biliary stenting for choledocholithiasis: Evaluation of stent-exchange intervals
por: Tohda, Gen, et al.
Publicado: (2018)

Neutrophile-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios as prognostic and response biomarkers for resectable locally advanced gastric cancer
por: Tomás, Tiago Cruz, et al.
Publicado: (2022)

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression
por: Li, You-Cai, et al.
Publicado: (2018)

Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma
por: Zhang, Yan-Hua, et al.
Publicado: (2020)

Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma
por: Chen, Ming-Yu, et al.
Publicado: (2020)

Prognostic predictors in patients with sepsis after gastrointestinal tumor surgery: A retrospective study
por: Chen, Ren-Xiong, et al.
Publicado: (2021)

Evaluating tumor-infiltrating lymphocytes in hepatocellular carcinoma using hematoxylin and eosin-stained tumor sections
por: Du, Min, et al.
Publicado: (2022)

Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma
por: Wang, Qiang, et al.
Publicado: (2019)

Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP
por: Wang, Ya-Kun, et al.
Publicado: (2018)

End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma
por: Kong, Fan-Hua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ajge4v3k1t8k4uml8hfk2lmaq9